Zoetis PE Ratio 2011-2018 | ZTS

Current and historical PE ratio for Zoetis (ZTS) from 2011 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Zoetis (ZTS) as of March 31, 2018 is 32.88.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $5.307B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.548B 11.24
Grifols (GRFS) Spain $14.606B 18.93
Jazz Pharmaceuticals (JAZZ) Ireland $10.609B 17.85
Neurocrine Biosciences (NBIX) United States $9.250B 0.00
Nektar Therapeutics (NKTR) United States $8.191B 0.00
Valeant Pharmaceuticals (VRX) Canada $8.160B 5.91
Sage Therapeutics (SAGE) United States $7.820B 0.00
Catalent (CTLT) United States $5.787B 26.95
Ionis Pharmaceuticals (IONS) United States $5.679B 0.00
United Therapeutics (UTHR) United States $5.432B 9.86
Loxo Oncology (LOXO) United States $5.384B 0.00
FibroGen (FGEN) United States $5.337B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.563B 18.70
Madrigal Pharmaceuticals (MDGL) United States $4.229B 0.00
Ironwood Pharmaceuticals (IRWD) United States $3.197B 0.00
Aerie Pharmaceuticals (AERI) United States $2.887B 0.00
Heron Therapeutics (HRTX) United States $2.788B 0.00
Portola Pharmaceuticals (PTLA) United States $2.649B 0.00
USANA Health Sciences (USNA) United States $2.628B 25.28
Endo (ENDP) Ireland $2.489B 3.39
TESARO (TSRO) United States $2.462B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.382B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.371B 43.79
Xencor (XNCR) United States $2.330B 0.00
Zogenix (ZGNX) United States $2.161B 0.00
PTC Therapeutics (PTCT) United States $1.684B 0.00
Corcept Therapeutics (CORT) United States $1.648B 27.50
Pacira Pharmaceuticals (PCRX) United States $1.483B 0.00
TherapeuticsMD (TXMD) United States $1.447B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.440B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.437B 0.00
Impax Laboratories (AMRX) United States $1.386B 29.78
ImmunoGen (IMGN) United States $1.346B 0.00
Radius Health (RDUS) United States $1.331B 0.00
Endocyte (ECYT) United States $1.200B 0.00
TRICIDA INC (TCDA) United States $1.170B 0.00
Esperion Therapeutics (ESPR) United States $1.134B 0.00
OptiNose (OPTN) United States $1.043B 0.00
Flexion Therapeutics (FLXN) United States $1.016B 0.00
Karyopharm Therapeutics (KPTI) United States $0.929B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.797B 0.00
GlycoMimetics (GLYC) United States $0.728B 0.00
ChemoCentryx (CCXI) United States $0.667B 46.83
Dova Pharmaceuticals (DOVA) United States $0.657B 0.00
Collegium Pharmaceutical (COLL) United States $0.652B 0.00
Odonate Therapeutics (ODT) United States $0.644B 0.00
Aclaris Therapeutics (ACRS) United States $0.636B 0.00
CASI Pharmaceuticals (CASI) United States $0.629B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.612B 0.00
Siga Technologies (SIGA) United States $0.581B 0.00
TRANSLATE BIO (TBIO) United States $0.575B 0.00
Akebia Therapeutics (AKBA) United States $0.566B 0.00
ArQule (ARQL) United States $0.534B 0.00
Depomed (DEPO) United States $0.522B 0.00
Lannett Co Inc (LCI) United States $0.517B 4.76
Majesco Entertainment (COOL) United States $0.503B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.503B 0.00
Dermira (DERM) United States $0.484B 0.00
VERRICA PHARMA (VRCA) United States $0.471B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.469B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.466B 0.00
FORTY SEVEN INC (FTSV) United States $0.461B 0.00
Concert Pharmaceuticals (CNCE) United States $0.398B 0.00
Mast Therapeutics (SVRA) United States $0.392B 0.00
XERIS PHARMA (XERS) United States $0.365B 0.00
Achaogen (AKAO) United States $0.350B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.347B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.341B 26.60
Catalyst Pharmaceuticals (CPRX) United States $0.335B 0.00
NEON THERAPEUTC (NTGN) United States $0.331B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.330B 0.00
Minerva Neurosciences (NERV) United States $0.329B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.323B 0.00
Tyme Technologies (TYME) United States $0.299B 0.00
Zafgen (ZFGN) United States $0.272B 0.00
DURECT (DRRX) United States $0.270B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.261B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.256B 0.00
Jounce Therapeutics (JNCE) United States $0.254B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Ocular Therapeutix (OCUL) United States $0.245B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.242B 0.00
CTI BioPharma (CTIC) United States $0.239B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.235B 0.00
Redhill Biopharma (RDHL) Israel $0.227B 0.00
Immune Design (IMDZ) United States $0.224B 0.00
Ardelyx (ARDX) United States $0.217B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.213B 0.00
ProNAi Therapeutics (SRRA) Canada $0.211B 0.00
IMV INC (IMV) Canada $0.207B 0.00
Aratana Therapeutics (PETX) United States $0.207B 0.00
Melinta Therapeutics (MLNT) United States $0.202B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.199B 0.00
ContraFect (CFRX) United States $0.195B 0.00
Neos Therapeutics (NEOS) United States $0.193B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.187B 0.00
Adherex Technologies (FENC) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.178B 0.00
Aldeyra Therapeutics (ALDX) United States $0.172B 0.00
Calithera Biosciences (CALA) United States $0.170B 0.00
MediWound (MDWD) Israel $0.169B 0.00
Opexa Therapeutics (ACER) United States $0.167B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.164B 0.00
MEI Pharma (MEIP) United States $0.159B 0.00
Molecular Templates (MTEM) United States $0.140B 0.00
Cardiome Pharma (CORV) Canada $0.136B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.134B 0.00
Forward Pharma (FWP) Denmark $0.130B 0.00
Juniper Pharmaceuticals (JNP) United States $0.127B 190.00
Iterum Therapeutics (ITRM) Ireland $0.123B 0.00
SteadyMed (STDY) Israel $0.122B 0.00
Otonomy (OTIC) United States $0.115B 0.00
Infinity Pharmaceuticals (INFI) United States $0.114B 0.00
Nivalis Therapeutics (ALPN) United States $0.114B 0.00
Recro Pharma (REPH) United States $0.113B 0.00
Affimed (AFMD) Germany $0.112B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
KalVista Pharmaceuticals (KALV) United States $0.100B 0.00
BioLineRx (BLRX) Israel $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.098B 0.00
SCYNEXIS (SCYX) United States $0.090B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.086B 0.00
KemPharm (KMPH) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.076B 9.81
Novan (NOVN) United States $0.076B 0.00
Trillium Therapeutics (TRIL) Canada $0.076B 0.00
Genocea Biosciences (GNCA) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.063B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.057B 0.00
Mannatechorporated (MTEX) United States $0.055B 13.40
Capnia (SLNO) United States $0.054B 0.00
Heat Biologics (HTBX) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.042B 38.50
Avenue Therapeutics (ATXI) United States $0.041B 0.00
Xenetic Biosciences (XBIO) United States $0.040B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.039B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.037B 0.00
HANCOCK JAFFE (HJLI) United States $0.036B 0.00
Biomerica (BMRA) United States $0.036B 0.00
Onconova Therapeutics (ONTX) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.93
IsoRay (ISR) United States $0.034B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.033B 0.00
Citius Pharmaceuticals (CTXR) United States $0.033B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.033B 0.00
Regulus Therapeutics (RGLS) United States $0.031B 0.00
Shineco (TYHT) China $0.031B 2.64
Lipocine (LPCN) United States $0.030B 0.00
NanoViricides (NNVC) United States $0.028B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Cyanotech (CYAN) United States $0.023B 22.36
Aviragen Therapeutics (VXRT) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Aradigm (ARDM) United States $0.022B 0.00
Intellipharmaceutics (IPCI) Canada $0.022B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Egalet (EGLT) United States $0.021B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.017B 0.00
Pain Therapeutics (PTIE) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
Skyline Medical (AIPT) United States $0.015B 0.00
India Globalization Capital (IGC) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
PharmAthene (ALT) United States $0.013B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.012B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
RXi Pharmaceuticals (RXII) United States $0.008B 0.00
Biostar Pharmaceuticals (BSPM) China $0.006B 3.33
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
ELECTROCORE LLC (ECOR) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00